Visa crushed earnings, and Mastercard results loom as the payment giants deal with Covid and enter the BNPL market. Read More...
Barrons.com
FDA Panel Backs Pfizer’s Covid Vaccine for Children 5 to 11
The Food and Drug Administration’s vaccines advisory committee on Tuesday voted overwhelmingly in favor of an emergency use authorization for Pfizer ‘s Covid-19 vaccine for children aged 5 to 11, though committee members raised concerns about the risk of side effects, and some said that only high-risk children should receive the vaccine. One committee member, Dr. Cody Meissner, speaking directly after the vote, said that he hoped that the vaccines advisory committee to the Centers for Disease Control and Prevention, which will consider the vaccine next week, would limit its recommendation to children with additional risk factors.
Add Comment